Vasomotor Rhinitis with Rhinorrhea (Runny Nose): After Topical Cromoglycate Has Not Achieved Its Goals

This protocol applies to a patient with vasomotor rhinitis whose dominant symptom is rhinorrhea (runny nose), with no nasal obstruction and no nasal congestion. When rhinorrhea is the sole presenting feature, therapy can be targeted precisely to that symptom.

Clinical Scenario

Isolated rhinorrhea — nasal discharge without obstruction or congestion. The absence of obstruction and congestion narrows the clinical picture and informs which topical options are most logically aligned with the presenting complaint.

Previous Treatment & Why It Was Not Sufficient

The prior step — intranasal topical cromoglycate (cromolyn sodium) — did not achieve the targeted goals of decreasing sneezing and congestion. This protocol represents the structured step taken after that shortfall.

Next-Line Approach (Partial Overview)

The next step involves switching to a different topical agent not yet tried. Several classes of topical therapy remain available for consideration. Which agent, how it is chosen, and how it is applied are detailed in the full protocol.

Instant Access to Structured Evidence-Based Regimens

References

If the presenting symptom is solely rhinorrhea, a topical anticholinergic is the logical first step.

Consider topical agent not yet tried: antihistamine, corticosteroid, anticholinergic, or cromoglycate.

View source ↗